- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.04. | Bullion Gold Resources Corp (2): Bullion receives TSX-V approval for Bousquet option | 1 | Stockwatch | ||
| 04.04. | Bullion Gold Resources Corporation: Bullion Gold Completes Transaction on Bousquet Property with Olympio Metals and Closes Financing | 1.579 | Newsfile | Montreal, Quebec--(Newsfile Corp. - April 4, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Company") announces that the option agreement on the Bousquet property with Olympio... ► Artikel lesen | |
| 28.03. | Bullion Gold Resources Corp (2): Bullion Gold sale of option for Bousquet | 1 | Stockwatch | ||
| 18.03. | Bullion Gold Resources Corp (2): Bullion Gold signs option agreement with Olympio | 1 | Stockwatch | ||
| 18.03. | Bullion Gold Resources Corporation: Bullion Gold Signs Option Agreement with Olympio Metals for the Bousquet Project | 446 | Newsfile | Montreal, Quebec--(Newsfile Corp. - March 18, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Company") announces the signing of an option agreement with Olympio Metals ("Olympio"... ► Artikel lesen | |
| 25.02. | Bullion Gold Resources Corp (2): Bullion Gold grants option to sell 80 per cent of Bousquet | 1 | Stockwatch | ||
| BULLION GOLD RESOURCES Aktie jetzt für 0€ handeln | |||||
| 25.02. | Bullion Gold Resources Corporation: Bullion Gold Grants Option on Its Bousquet Project to Olympio Metals | 476 | Newsfile | Montreal, Quebec--(Newsfile Corp. - February 24, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Company") announces the signing of a letter of intent with Olympio Metals (ASX:... ► Artikel lesen | |
| 14.01. | Bullion Gold Resources Corp (2): Bullion Gold appoints Morissette as president, CEO | 1 | Stockwatch | ||
| 14.01. | Bullion Gold Resources Corporation: Morissette Joins Bullion Gold to Develop the Bodo Project | 707 | Newsfile | Montreal, Quebec--(Newsfile Corp. - January 14, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Company") announces the appointment of Mr. Guy Morissette as President and Chief... ► Artikel lesen | |
| 03.01. | Bullion Gold Resources Corp (2): Bullion Gold closes $448,450 private placement | 1 | Stockwatch | ||
| 03.01. | Bullion Gold Resources Corporation: Bullion Gold Completes Private Placement | 3.348 | Newsfile | Montréal, Québec--(Newsfile Corp. - January 3, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Corporation") announces that it has closed a private placement (the "Offering")... ► Artikel lesen | |
| 04.12.24 | Bullion Gold Resources Corp (2): Bullion Gold appoints Moore, Gervais as directors | 3 | Stockwatch | ||
| 04.12.24 | Bullion Gold Resources Corporation: Moore and Gervais Appointed Directors of Bullion Gold Resources | 855 | Newsfile | Montreal, Quebec--(Newsfile Corp. - December 4, 2024) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce the appointments of MM. Jean-David Moore and... ► Artikel lesen | |
| 13.11.24 | Bullion Gold Resources Corp (2): Bullion Gold arranges $1-million private placement | 1 | Stockwatch | ||
| 13.11.24 | Bullion Gold Resources Corporation: Bullion Prepares $1M Financing and Presents Summary of Its Gold and Polymetallic Projects | 503 | Newsfile | Montreal, Quebec--(Newsfile Corp. - November 13, 2024) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Company") will undertake a non-brokered private placement for minimum aggregate... ► Artikel lesen | |
| 27.08.24 | Bullion Gold Resources Corporation: Bullion Gold Bodo Project: Samples Reveal Significant Gold, Silver and Copper Grades | 877 | Newsfile | Montreal, Quebec--(Newsfile Corp. - August 27, 2024) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") announces new sampling results from its Bodo project. Despite the short... ► Artikel lesen | |
| 18.06.24 | Bullion Gold Resources Corporation: Bullion Gold Discovers New Massive Sulphide Zone on Bodo Property, James Bay, Quebec | 346 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 18, 2024) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "The Company") announces that it has completed the first phase of its 2024 exploration... ► Artikel lesen | |
| 14.06.24 | Bullion Gold Resources Corporation: Bullion Closes Private Placement | 442 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 13, 2024) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "The Company") is pleased to announce that it has closed a private placement (the "Offering")... ► Artikel lesen | |
| 03.06.24 | Bullion Gold Resources Corporation: Bullion Hires Momentum PR Firm as Work Begins on Rivon Polymetallic Showing at Bodo Project | 261 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 3, 2024) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "The Company") is pleased to announce that it has retained the services of Momentum PR... ► Artikel lesen | |
| 21.05.24 | Bullion Gold Resources Corporation: Bullion Gold Starts Work on Bodo | 257 | Newsfile | Montreal, Quebec--(Newsfile Corp. - May 21, 2024) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "The Company") will begin an initial exploration program starting June 2024 on its Bodo... ► Artikel lesen |
Seite:
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MURAL ONCOLOGY | 2,400 | 0,00 % | Raymond James cuts Mural Oncology target to $4, retains outlook | ||
| SUMMIT THERAPEUTICS | 24,650 | 0,00 % | Here's Why Summit Therapeutics Stock Soared 15% on Friday | ||
| TEMPUS AI | 42,950 | 0,00 % | Illumina, Tempus AI To Collaborate To Accelerate Genomic AI Innovation | SAN DIEGO (dpa-AFX) - Illumina Inc. (ILMN) and Tempus AI, Inc. (TEM), Tuesday announced a collaboration to accelerate clinical adoption of next-generation sequencing tests through novel evidence... ► Artikel lesen | |
| ADMA BIOLOGICS | 22,150 | 0,00 % | ADMA Biologics, Inc.: ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update | FY 2024 Total Revenue of $426.5 Million, a 65% YoY Increase FY 2024 GAAP Net Income of $197.7 Million, Including an $84.3 Million Valuation Allowance Tax Benefit FY 2024 Adjusted EBITDA(1)... ► Artikel lesen | |
| KYMERA THERAPEUTICS | 25,460 | 0,00 % | Kymera Therapeutics, Inc.: Kymera Therapeutics Appoints Noah Goodman as Chief Business Officer | WATERTOWN, Mass., April 09, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines... ► Artikel lesen | |
| QIAGEN | 36,890 | -0,77 % | AKTIEN IM FOKUS: Pharmawerte unter Druck - Zölle treffen Sektor hart | FRANKFURT (dpa-AFX) - Die eigentlich als defensiv geltenden Pharmawerte sind im frühen Handel am Mittwoch mit deutlichen Abgaben aufgefallen. Der Branchenindex Stoxx Europe 600 Health Care ist in einem... ► Artikel lesen | |
| VERVE THERAPEUTICS | 4,970 | 0,00 % | Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9 | Single infusion of VERVE-102 led to dose-dependent decreases in blood PCSK9 and LDL-C, with mean reduction in LDL-C of 53% and a maximum reduction of 69% observed in the 0.6 mg/kg dose cohort VERVE-102... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 5,630 | 0,00 % | Jim Cramer on Recursion (RXRX): "The AI Company That Has It - Backed by Jensen Huang and NVIDIA" | ||
| DOGWOOD THERAPEUTICS | 4,130 | 0,00 % | Dogwood Therapeutics, Inc. Receives Nasdaq Confirmation of Compliance | ATLANTA, April 11, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the "Company"), a development-stage biopharmaceutical company focused on developing new medicines to treat pain... ► Artikel lesen | |
| NUVALENT | 70,82 | 0,00 % | Nuvalent, Inc.: Nuvalent Outlines Pipeline and Business Progress, Reiterates Key Anticipated Milestones, and Reports Fourth Quarter and Full Year 2024 Financial Results | Topline pivotal data expected in 2025 for both TKI pre-treated ROS1-positive and TKI pre-treated ALK-positive NSCLC populations
First NDA submission planned for... ► Artikel lesen | |
| SPRINGWORKS THERAPEUTICS | 37,600 | 0,00 % | SpringWorks Therapeutics, Inc.: SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates | - Achieved $61.5 million and $172.0 million in fourth quarter and full year 2024 OGSIVEO® (nirogacestat) U.S. net product revenues, respectively - - Received FDA approval of GOMEKLI (mirdametinib)... ► Artikel lesen | |
| EDGEWISE THERAPEUTICS | 13,020 | 0,00 % | Biotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & More | ||
| ARCUTIS BIOTHERAPEUTICS | 13,180 | 0,00 % | Arcutis Biotherapeutics, Inc.: Arcutis Announces Chief Financial Officer Transition | WESTLAKE VILLAGE, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations... ► Artikel lesen | |
| IMMUNOVANT | 15,470 | 0,00 % | Immunovant Inc.: Immunovant Announces Positive Results for Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Studies | Pivotal study in MG met primary endpoint of change from baseline in MG-ADL in AChR+ population at 12 weeks, with a 5.6 point improvement in the higher dose arm (with 74% mean IgG reduction) and a... ► Artikel lesen | |
| EVOTEC | 5,740 | -3,43 % | Evotec Aktie im Keller, aber mit Chancen: So geht es weiter | Seit nunmehr fast einem Jahr pendelt die Evotec Aktie in einer weiten Range zwischen 5,06 und 10,66 Euro - eine lange Seitwärtsbewegung nach einer herben Baisse zuvor. Der frühere Glanz ist verblasst... ► Artikel lesen |
BULLION GOLD RESOURCES CORPORATION gehört der Branche Biotechnologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BULLION GOLD RESOURCES CORPORATION finden Sie auf Wallstreet Online.
